MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/ijwh.s485822

Медицинская библиотека · International journal of women's health · 2025

Perinatal Management of Neuromyelitis Optica Spectrum Disorder in Pregnancy: A Case Report.

Politikos Ioannis, Lau Carmen, Devlin Sean M, Quach Sean, Lin Andrew, Perales Miguel-Angel, Shah Gunjan L, Seo Susan K, Papanicolaou Genovefa A, Barker Juliet N

Клинический случайСтатьяПеревод в очереди

Аннотация

Cord blood transplantation (CBT) can be complicated by a high incidence of clinically significant cytomegalovirus infection (csCMVi). We have investigated the efficacy of extended letermovir prophylaxis in seropositive adult CBT recipients. The aim was to continue prophylaxis for ≥6 months (insurance permitting). By day 100, the incidence of csCMVi was 0% in 28 patients who received letermovir prophylaxis. Moreover, of 24 patients alive at day 100, none had csCMVi by day 180, having continued prophylaxis for all (n = 20) or part (n = 4) of that period. Overall, 20 patients stopped letermovir at a median of 354 days (range, 119-455 days) posttransplant, with only 5 requiring 1 (n = 4) or 2 (n = 1) courses of valganciclovir (median total duration, 58 days; range, 12-67 days) for postprophylaxis viremia, with no subsequent csCMVi. There were no toxicities attributable to letermovir. Of the 62 historic control subjects who received acyclovir only, 51 developed csCMVi (median onset, 34 days; range, 5-74 days), for a day 100 incidence of 82% (95% confidence interval, 73-92). Seven patients developed proven/probable CMV disease, and 6 died before day 100 (3 with proven/probable CMV pneumonia). Forty-five patients required extended therapy during the first 6 months for 1 (n = 10), 2 (n = 14), or 3/persistent (n = 21) csCMVi, with 43 (84%) of 51 developing significant treatment toxicities. Letermovir is a highly effective, well-tolerated prophylaxis that mitigates CMV infection, CMV-related mortality, and antiviral therapy toxicities in CBT recipients. Our data support prophylaxis duration of at least 6 months after CBT.

Для цитирования: Politikos Ioannis, Lau Carmen, Devlin Sean M, Quach Sean, Lin Andrew, Perales Miguel-Angel, Shah Gunjan L, Seo Susan K, Papanicolaou Genovefa A, Barker Juliet N. Perinatal Management of Neuromyelitis Optica Spectrum Disorder in Pregnancy: A Case Report.. International journal of women's health. 2025. DOI: 10.2147/ijwh.s485822.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.